NCT02163824

Timeline

Start date

May 1, 2014

Primary completion

Dec 1, 2014

Completion date

Mar 1, 2015

First posted

—

Last posted

—

Enrollment

380

Arms / groups

4 / —

Source

AACT · pre-existing

Sponsors

• Kala Pharmaceuticals, Inc.Lead sponsor
• Price Vision GroupOverall official - principal investigator
• Duke UniversityOverall official - principal investigator
• Virginia Eye ConsultantsOverall official - principal investigator
• Raymond Fong, MDPCOverall official - principal investigator
• Wolstan & Goldberg Eye AssociatesOverall official - principal investigator
• Rochester Ophthalmological Group, PCOverall official - principal investigator
• Martel Eye Medical GroupOverall official - principal investigator
• Kozlovsky Delay & Winter Eye Consultants, LLCOverall official - principal investigator
• R&R Eye Research, LLCOverall official - principal investigator
• Tauber Eye CenterOverall official - principal investigator
• Tekwani Vision CenterOverall official - principal investigator
• Sall Research Medical CenterOverall official - principal investigator
• John-Kenyon American Eye InstituteOverall official - principal investigator
• The Eye Center of ColumbusOverall official - principal investigator
• Westfield Nevada Eye and EarOverall official - principal investigator
• Westside Research, LLCOverall official - principal investigator
• University of RochesterOverall official - principal investigator
• University of CincinnatiOverall official - principal investigator
• Houston Eye AssociatesOverall official - principal investigator

Drugs studied

• loteprednol

Indications studied

• Inflammation